✦ LIBER ✦

538 DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION DO NOT COMPROMISE THE OUTCOME

✍ Scribed by S. Frankova; J. Sperl; P. Trunecka; M. Adamec; J. Spicak

Book ID: 117379683
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 37 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60540-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and outcome of De Novo maligna

Incidence and outcome of De Novo malignancies after liver transplantation

✍ M.L Galve; V Cuervas-Mons; J Figueras; I Herrero; M Mata; G Clemente; M Prieto; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 112 KB

De Novo Malignancies After Liver Transpl

De Novo Malignancies After Liver Transplantation: Incidence Comparison With the Korean Cancer Registry

✍ H.W. Park; S. Hwang; C.S. Ahn; K.H. Kim; D.B. Moon; T.Y. Ha; G.W. Song; D.H. Jun 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 117 KB

CD28 expression by peripheral blood lymp

CD28 expression by peripheral blood lymphocytes as a potential predictor of the development of de novo malignancies in long-term survivors after liver transplantation

✍ Emmanuel Boleslawski; Samia Ben Othman; Lynda Aoudjehane; Sandrine Chouzenoux; O 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

At present, no method is available for accurately monitoring the degree of immunosuppression induced by antirejection therapies. The aim of this study was to determine whether CD28 and CD38 expression by peripheral blood mononuclear cells could be useful in predicting the development of de novo mali